Michael Caplan

Dr. Michael Caplan


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2010 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
ACArthit Chairoungdua
Arthit Chairoungdua
DSDanielle L. Smith
Danielle L. Smith
PPPierre Pochard
Pierre Pochard
MHMichael Hull
Michael Hull
MCMichael Caplan
Michael Caplan
CD82 and CD9 are tetraspanin membrane proteins that can function as suppressors of tumor metastasis. Expression of CD9 and CD82 in transfected cells strongly suppresses β-catenin–mediated Wnt signaling activity and induces a significant decrease in β-catenin protein levels. Inhibition of Wnt/β-catenin signaling is independent of glycogen synthase kinase-3β and of the proteasome- and lysosome-mediated protein degradation pathways. CD82 and CD9 expression induces β-catenin export via exosomes, which is blocked by a sphingomyelinase inhibitor, GW4869. CD82 fails to induce exosome release of β-catenin in cells that express low levels of E-cadherin. Exosome release from dendritic cells generated from CD9 knockout mice is reduced compared with that from wild-type dendritic cells. These results suggest that CD82 and CD9 down-regulate the Wnt signaling pathway through the exosomal discharge of β-catenin. Thus, exosomal packaging and release of cytosolic proteins can modulate the activity of cellular signaling pathways.

23 April 2004 in Science
Verified
Journal Article
Closed access
PDF file
MEMarie E. Egan
Marie E. Egan
MPMarilyn Pearson
Marilyn Pearson
SWScott A. Weiner
Scott A. Weiner
VRVanathy Rajendran
Vanathy Rajendran
DRDaniel Rubin
Daniel Rubin
MCMichael Caplan
Michael Caplan
Cystic fibrosis is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). The most common mutation, ΔF508, results in the production of a misfolded CFTR protein that is retained in the endoplasmic reticulum and targeted for degradation. Curcumin is a nontoxic Ca–adenosine triphosphatase pump inhibitor that can be administered to humans safely. Oral administration of curcumin to homozygous ΔF508 CFTR mice in doses comparable, on a weight-per-weight basis, to those well tolerated by humans corrected these animals' characteristic nasal potential difference defect. These effects were not observed in mice homozygous for a complete knockout of the CFTR gene. Curcumin also induced the functional appearance of ΔF508 CFTR protein in the plasma membranes of transfected baby hamster kidney cells. Thus, curcumin treatment may be able to correct defects associated with the homozygous expression of ΔF508 CFTR.

24 January 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
VTVinita Takiar
Vinita Takiar
SNSaori Nishio
Saori Nishio
PSPatricia Seo-Mayer
Patricia Seo-Mayer
JKJ. Darwin King
J. Darwin King
HLHui Li
Hui Li
MCMichael Caplan
Michael Caplan
Renal cyst development and expansion in autosomal dominant polycystic kidney disease (ADPKD) involves both fluid secretion and abnormal proliferation of cyst-lining epithelial cells. The chloride channel of the cystic fibrosis transmembrane conductance regulator (CFTR) participates in secretion of cyst fluid, and the mammalian target of rapamycin (mTOR) pathway may drive proliferation of cyst epithelial cells. CFTR and mTOR are both negatively regulated by AMP-activated protein kinase (AMPK). Metformin, a drug in wide clinical use, is a pharmacological activator of AMPK. We find that metformin stimulates AMPK, resulting in inhibition of both CFTR and the mTOR pathways. Metformin induces significant arrest of cystic growth in both in vitro and ex vivo models of renal cystogenesis. In addition, metformin administration produces a significant decrease in the cystic index in two mouse models of ADPKD. Our results suggest a possible role for AMPK activation in slowing renal cystogenesis as well as the potential for therapeutic application of metformin in the context of ADPKD.

14 November 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
LZLi Zhang
Li Zhang
JLJi Li
Ji Li
LYLawrence H. Young
Lawrence H. Young
MCMichael Caplan
Michael Caplan
AMP activated protein kinase (AMPK), a sensor of cellular energy status in all eukaryotic cells, is activated by LKB1-dependent phosphorylation. Recent studies indicate that activated LKB1 induces polarity in epithelial cells and that this polarization is accompanied by the formation of tight junction structures. We wished to determine whether AMPK also contributes to the assembly of tight junctions in the epithelial cell polarization process. We found that AMPK is activated during calcium-induced tight junction assembly. Activation of AMPK by 5-aminoimidazole-4-carboxamide ribonucleoside facilitates tight junction assembly under conditions of normal extracellular Ca 2+ concentrations and initiates tight junction assembly in the absence of Ca 2+ as revealed by the relocation of zonula occludens 1, the establishment of transepithelial electrical resistance, and the paracellular flux assay. Expression of a dominant negative AMPK construct inhibits tight junction assembly in MDCK cells, and this defect in tight junction assembly can be partially ameliorated by rapamycin. These results suggest that AMPK plays a role in the regulation of tight junction assembly.

15 November 2010 in Journal of Cell Biology
Verified
Journal Article
Open access
HCHannah C. Chapin
Hannah C. Chapin
MCMichael Caplan
Michael Caplan
Polycystic kidney disease is a common genetic disorder in which fluid-filled cysts displace normal renal tubules. Here we focus on autosomal dominant polycystic kidney disease, which is attributable to mutations in the PKD1 and PKD2 genes and which is characterized by perturbations of renal epithelial cell growth control, fluid transport, and morphogenesis. The mechanisms that connect the underlying genetic defects to disease pathogenesis are poorly understood, but their exploration is shedding new light on interesting cell biological processes and suggesting novel therapeutic targets.

10 February 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
JPJennifer L. Pluznick
Jennifer L. Pluznick
DZDong-Jing Zou
Dong-Jing Zou
XZXiaohong Zhang
Xiaohong Zhang
QYQingshang Yan
Qingshang Yan
DRDiego J. Rodriguez-Gil
Diego J. Rodriguez-Gil
MCMichael Caplan
Michael Caplan
Olfactory-like chemosensory signaling occurs outside of the olfactory epithelium. We find that major components of olfaction, including olfactory receptors (ORs), olfactory-related adenylate cyclase (AC3) and the olfactory G protein (G olf ), are expressed in the kidney. AC3 and G olf colocalize in renal tubules and in macula densa (MD) cells which modulate glomerular filtration rate (GFR). GFR is significantly reduced in AC3 −/− mice, suggesting that AC3 participates in GFR regulation. Although tubuloglomerular feedback is normal in these animals, they exhibit significantly reduced plasma renin levels despite up-regulation of COX-2 expression and nNOS activity in the MD. Furthermore, at least one member of the renal repertoire of ORs is expressed in a MD cell line. Thus, key components of olfaction are expressed in the renal distal nephron and may play a sensory role in the MD to modulate both renin secretion and GFR.